Literature DB >> 17520476

Kv1 potassium channel C-terminus constant HRETE region: arginine substitution affects surface protein level and conductance level of subfamily members differentially.

Jing Zhu1, Barbara Gomez, Itaru Watanabe, William B Thornhill.   

Abstract

We have shown previously that truncating all of the variable cytoplasmic C-terminus of Kv1.1 potassium channels to G421stop had only a small inhibitory effect on their cell surface conductance density levels and cell surface protein levels. Here we investigated the role of a highly conserved cytoplasmic C-terminal charged region of five amino acids (HRETE) of the S6 transmembrane domain in the protein and conductance expression of Kv1.1, Kv1.2, and Kv1.4 channels. For Kv1.1 we found that E420stop, T419stop, and E418stop showed cell surface conductance densities and cell surface protein levels similar to full length control, whereas R417stop and H416stop exhibited essentially no conductance but their surface protein levels were similar to full length control. A bulky non-negatively charged hydrophilic amino acid at position 417 appeared to be critical for wild type gating of Kv1.1 because R417K and R417Q rescued conductance levels whereas R417A or R417E did not. The R417A mutation in the full length Kv1.1 also exhibited surface protein levels similar to control but it did not exhibit significant conductance. In contrast, mutation of the equivalent arginine to alanine in full length Kv1.2 and Kv1.4 appeared to have little or no effect on channel conductance but rather decreased cell surface protein levels by inducing partial high ER retention. These findings are consistent with the notion that the arginine amino acid in the HRETE region plays a different role in affecting conductance levels or cell surface protein levels of very closely related Kv1 potassium channels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520476     DOI: 10.1080/09687860601066309

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  7 in total

1.  The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse.

Authors:  Orsolya Szilágyi; Anita Boratkó; György Panyi; Péter Hajdu
Journal:  Pflugers Arch       Date:  2013-04-04       Impact factor: 3.657

2.  Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Ito channel complex.

Authors:  Diego Cotella; Susanne Radicke; Alessio Bortoluzzi; Ursula Ravens; Erich Wettwer; Claudio Santoro; Daniele Sblattero
Journal:  Pflugers Arch       Date:  2010-03-31       Impact factor: 3.657

3.  The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit.

Authors:  Laura Solé; Sara R Roig; Albert Vallejo-Gracia; Antonio Serrano-Albarrás; Ramón Martínez-Mármol; Michael M Tamkun; Antonio Felipe
Journal:  J Cell Sci       Date:  2016-10-06       Impact factor: 5.285

4.  Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.

Authors:  Joost H Heeroma; Christian Henneberger; Sanjeev Rajakulendran; Michael G Hanna; Stephanie Schorge; Dimitri M Kullmann
Journal:  Dis Model Mech       Date:  2009-09-24       Impact factor: 5.758

5.  Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a.

Authors:  John M Spear; Dolly Al Koborssy; Austin B Schwartz; Adam J Johnson; Anjon Audhya; Debra A Fadool; Scott M Stagg
Journal:  BMC Biochem       Date:  2015-07-10       Impact factor: 4.059

6.  The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin.

Authors:  Peter Hajdu; Geoffrey V Martin; Ameet A Chimote; Orsolya Szilagyi; Koichi Takimoto; Laura Conforti
Journal:  Mol Biol Cell       Date:  2015-03-04       Impact factor: 4.138

7.  The C-terminal HRET sequence of Kv1.3 regulates gating rather than targeting of Kv1.3 to the plasma membrane.

Authors:  Orsolya Voros; Orsolya Szilagyi; András Balajthy; Sándor Somodi; Gyorgy Panyi; Péter Hajdu
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.